TherapeuticsMD | TXMD - Vermögenswerte





Vermögenswerte Veränderung Datum
AbbVie USD 136.46B 2.5B 2026-03
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Novo Nordisk DKK 76.18B 412.98B 2025-06
Pfizer USD 207.62B 542M 2026-03
TherapeuticsMD USD 40.13M 1.96M 2024-06